Literature DB >> 19015435

Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib.

Jeffrey C Donovan, Danny M Ghazarian, James C Shaw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19015435     DOI： 10.1001/archderm.144.11.1524

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  A case of cicatricial alopecia associated with erlotinib.

Authors:  Bo Hee Yang; Chan Yl Bang; Ji Won Byun; Sung Hyub Han; Hee Jin Song; Seung Gyun In; Jeong Hyun Shin; Gwang Seong Choi
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

Review 2.  A comparison of epithelial-to-mesenchymal transition and re-epithelialization.

Authors:  Philip L Leopold; Jan Vincent; Hongjun Wang
Journal:  Semin Cancer Biol       Date:  2012-07-31       Impact factor: 15.707

Review 3.  Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors.

Authors:  L Peuvrel; C Bachmeyer; Z Reguiai; J B Bachet; T André; R J Bensadoun; O Bouché; M Ychou; B Dréno
Journal:  Support Care Cancer       Date:  2012-02-24       Impact factor: 3.359

Review 4.  Epidermal growth factor receptor inhibitors: a review of cutaneous adverse events and management.

Authors:  K Chanprapaph; V Vachiramon; P Rattanakaemakorn
Journal:  Dermatol Res Pract       Date:  2014-03-02

Review 5.  Dermatologic conditions in women receiving systemic cancer therapy.

Authors:  Michelle N Ferreira; Julie Y Ramseier; Jonathan S Leventhal
Journal:  Int J Womens Dermatol       Date:  2019-11-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.